SCHEMBL294976

SCHEMBL294976

O=C(O)CCC1OCC2(CO1)COC(CCC(=O)O)OC2

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
SUCNR1 Q9BXA5 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
HTT P42858 1/20 0.32
HSD17B10 Q99714 2/20 0.32
CYP2C9 P11712 2/20 0.32
MEN1 O00255 1/20 0.32
NR1I2 O75469 1/20 0.32
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32
THRB P10828 1/20 0.32
TSHR P16473 1/20 0.32
ACHE P22303 1/20 0.32
APEX1 P27695 1/20 0.32
RECQL P46063 1/20 0.32
BLM P54132 1/20 0.32
PMP22 Q01453 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9868722 0.83
SCHEMBL2578186 0.81 LMNA (0.40) LMNAALKBH5SUCNR1EGLN1HTT
SCHEMBL13523549 0.79
SCHEMBL18192041 0.77 FFAR3 (0.31)
SCHEMBL22104096 0.77 CYP2C19 (0.40) CYP2C9MEN1KMT2ACYP1A2CYP2D6
SCHEMBL12723334 0.77 ALDH1A1 (0.42) LMNAALKBH5SUCNR1EGLN1HTT
SCHEMBL294637 0.76 TSHR (0.43) LMNAHTTHSD17B10MEN1ALDH1A1
SCHEMBL4412118 0.76 POLB (0.38) HTTMEN1ALDH1A1POLBKMT2A
SCHEMBL23671744 0.73 ALOX5 (0.44) LMNAHSD17B10CYP2C9MEN1ALDH1A1
SCHEMBL536203 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-PP36652-P2 Catharanthus plant named ‘CaTU 1915’ SUNTORY FLOWERS LIMITED (JP) 2025-05-06 US claimed
US-PP36460-P2 Catharanthus plant named ‘CaTU 1917’ SUNTORY FLOWERS LIMITED (JP) 2025-02-18 US claimed
CN-116978593-A Multi-degree-of-freedom underwater connection pipe video inspection system and method 三门核电有限公司 2023-10-31 CN claimed
EP-1262524-B1 Polyester based resin composition and molded product therefrom MITSUBISHI GAS CHEMICAL CO (JP) 2005-08-24 EP claimed
JP-9169831-A None JP disclosed
JP-4088078-A None JP disclosed
JP-7242654-A None JP disclosed
EP-4019249-B1 RESIN LAYERED BODY MITSUBISHI GAS CHEMICAL CO (JP) 2026-05-06 EP disclosed
US-20260062435-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF WAVE LIFE SCIENCES LTD (SG) 2026-03-05 US disclosed
CN-120041591-A Microbial marker related to refractory diarrhea, product and application thereof 福建医科大学附属协和医院 2025-05-27 CN disclosed
US-PP36652-P2 Catharanthus plant named ‘CaTU 1915’ SUNTORY FLOWERS LIMITED (JP) 2025-05-06 US disclosed
US-PP36652-P2 Catharanthus plant named ‘CaTU 1915’ SUNTORY FLOWERS LIMITED (JP) 2025-05-06 US disclosed
JP-H09169831-A EPOXY RESIN COMPOSITION YUKA SHELL EPOXY KK 1997-06-30 JP disclosed
JP-H07242654-A DIALLYL ESTER OR DIMETHALLYL ESTER COMPOUND MITSUBISHI CHEM CORP 1995-09-19 JP disclosed
EP-0104837-B1 Latent curing agents for epoxy resins AJINOMOTO KK (JP) 1994-01-26 EP disclosed
EP-0569044-A1 Latent curing agents for epoxy resins AJINOMOTO CO., INC. (JP) 1993-11-10 EP disclosed
JP-H0488078-A NEW ADHESIVE COMPOSITION AJINOMOTO CO INC 1992-03-19 JP disclosed
US-4689388-A POLYHYDRAZIDE, LATENT CURING AGENT, DICYANDIAMIDE, IMIDAZOLE OR DERIVATIVE AJINOMOTO CO., INC. (JP) 1987-08-25 US disclosed
US-4542202-A EPOXY COMPOUND WITH A HYDROXY, MERCAPTO, OR HYDRAZIDE MODIFIED TERTIARY AMINE AJINOMOTO CO., INC. (JP) 1985-09-17 US disclosed
EP-0104837-A2 Latent curing agents for epoxy resins AJINOMOTO CO., INC. (JP) 1984-04-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062435-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF NSUN3, METTL3, RNASE1 LMNA 921/4885ALKBH5 90/4885SUCNR1 2539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.